Dominant TRPV4 mutations in nonlethal and lethal metatropic dysplasia
- 22 April 2010
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 152A (5) , 1169-1177
Abstract
Metatropic dysplasia is a clinical heterogeneous skeletal dysplasia characterized by short extremities, a short trunk with progressive kyphoscoliosis, and craniofacial abnormalities that include a prominent forehead, midface hypoplasia, and a squared‐off jaw. Dominant mutations in the gene encoding TRPV4, a calcium permeable ion channel, were identified all 10 of a series of metatropic dysplasia cases, ranging in severity from mild to perinatal lethal. These data demonstrate that the lethal form of the disorder is dominantly inherited and suggest locus homogeneity in the disease. Electrophysiological studies demonstrated that the mutations activate the channel, indicating that the mechanism of disease may result from increased calcium in chondrocytes. Histological studies in two cases of lethal metatropic dysplasia revealed markedly disrupted endochondral ossification, with reduced numbers of hypertrophic chondrocytes and presence of islands of cartilage within the zone of primary mineralization. These data suggest that altered chondrocyte differentiation in the growth plate leads to the clinical findings in metatropic dysplasia.Keywords
This publication has 25 references indexed in Scilit:
- Mutations in the Gene Encoding the Calcium-Permeable Ion Channel TRPV4 Produce Spondylometaphyseal Dysplasia, Kozlowski Type and Metatropic DysplasiaThe American Journal of Human Genetics, 2009
- Hypotonic shocks activate rat TRPV4 in yeast in the absence of polyunsaturated fatty acidsFEBS Letters, 2009
- TRPV4-Mediated Calcium Influx Regulates Terminal Differentiation of OsteoclastsCell Metabolism, 2008
- Interplay between TRP channels and the cytoskeleton in health and diseaseEuropean Journal of Cell Biology, 2008
- Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmiaNature Genetics, 2008
- Functional Gene Screening System Identified TRPV4 as a Regulator of Chondrogenic DifferentiationJournal of Biological Chemistry, 2007
- Metatropic dysplasia: Clinical and radiographic findings in 11 patients demonstrating long‐term natural historyAmerican Journal of Medical Genetics Part A, 2007
- S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytesEMBO Reports, 2007
- Marked Attenuation of Inflammatory Mediator-Induced C-Fiber Sensitization for Mechanical and Hypotonic Stimuli in TRPV4−/− MiceMolecular Pain, 2007
- The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilageArthritis & Rheumatism, 2004